Articles (34)
Articles
05/04/2021
Immunai Recognized by Fast Company’s 2021 World Changing Ideas Awards
Articles
03/25/2021
Immunai Using Acquisition, Funding to Shift Into Functional Work
Articles
03/25/2021
Immunai acquires single-cell data developer Dropprint Genomics to build out its immune system atlas
Articles
03/25/2021
Immunai Acquires Dropprint Genomics and Strengthens Leadership Team with Experts in Immunology to Expand Target Discovery Capabilities
Articles
03/04/2021
Immune Cell Profiles Reveal Cancer’s Leading Indicators
Articles
02/11/2021
Wading deeper into target discovery and validation, Immunai bags $60M to beef up both AI algorithms and lab benches
Articles
02/11/2021
Biotech firm Immunai raises $60 million in private funding round
Articles
02/11/2021